Back to LCTX
Kestra Advisory Services, LLC → LCTX
Kestra Advisory Services, LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
5
Latest value
$27K
Q3 2026
Peak value
$50K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $17K |
| Q4 2025 | $46K |
| Q1 2026 | $44K |
| Q2 2026 | $50K |
| Q3 2026 | $27K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $27K | 27.8K | — | — |
| Q2 2026 | $50K | 37.8K | — | — |
| Q1 2026 | $44K | 27.8K | — | — |
| Q4 2025 | $46K | 27.7K | — | — |
| Q3 2025 | $17K | 10.1K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M